Authors:
Wood, MD
Reavill, C
Trail, B
Wilson, A
Stean, T
Kennett, GA
Lightowler, S
Blackburn, TP
Thomas, D
Gager, TL
Riley, G
Holland, V
Bromidge, SM
Forbes, IT
Middlemiss, DN
Citation: Md. Wood et al., SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety, NEUROPHARM, 41(2), 2001, pp. 186-199
Authors:
Bromidge, SM
Dabbs, S
Davies, S
Duckworth, DM
Forbes, IT
Jones, GE
Jones, J
King, FD
Saunders, DV
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Riley, GJ
Trail, B
Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroaryloxy)heteroaryl]carbamoyl]indolines: Novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolyticagents, BIOORG MED, 10(16), 2000, pp. 1863-1866
Authors:
Bromidge, SM
Davies, S
Duckworth, DM
Forbes, IT
Jones, GE
Jones, J
King, FD
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Riley, GJ
Trail, B
Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orallyactive 5-HT2C receptor inverse agonists, BIOORG MED, 10(16), 2000, pp. 1867-1870
Authors:
Clapham, JC
Arch, JRS
Chapman, H
Haynes, A
Lister, C
Moore, GBT
Piercy, V
Carter, SA
Lehner, I
Smith, SA
Beeley, LJ
Godden, RJ
Herrity, N
Skehel, M
Changani, KK
Hockings, PD
Reid, DG
Squires, SM
Hatcher, J
Trail, B
Latcham, J
Rastan, S
Harper, AJ
Cadenas, S
Buckingham, JA
Brand, MD
Abuin, A
Citation: Jc. Clapham et al., Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean, NATURE, 406(6794), 2000, pp. 415-418
Authors:
Reavill, C
Taylor, SG
Wood, MD
Ashmeade, T
Austin, NE
Avenell, KY
Boyfield, I
Branch, CL
Cilia, J
Coldwell, MC
Hadley, MS
Hunter, AJ
Jeffrey, P
Jewitt, F
Johnson, CN
Jones, DNC
Medhurst, AD
Middlemiss, DN
Nash, DJ
Riley, GJ
Routledge, C
Stemp, G
Thewlis, KM
Trail, B
Vong, AKK
Hagan, JJ
Citation: C. Reavill et al., Pharmacological actions of a novel, high-affinity, and selective human dopamine D-3 receptor antagonist, SB-277011-A, J PHARM EXP, 294(3), 2000, pp. 1154-1165
Authors:
Bromidge, SM
Dabbs, S
Davies, DT
Davies, S
Duckworth, DM
Forbes, IT
Gaster, LM
Ham, P
Jones, GE
King, FD
Mulholland, KR
Saunders, DV
Wyman, PA
Blaney, FE
Clarke, SE
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Trail, B
Riley, GJ
Wood, MD
Citation: Sm. Bromidge et al., Biarylcarbamoylindolines are novel and selective 5-HT2C receptor inverse agonists: Identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent, J MED CHEM, 43(6), 2000, pp. 1123-1134
Authors:
Kennett, G
Lightowler, S
Trail, B
Bright, F
Bromidge, S
Citation: G. Kennett et al., Effects of RO 60 0175, a 5-HT2C receptor agonist, in three animal models of anxiety, EUR J PHARM, 387(2), 2000, pp. 197-204
Citation: Ga. Kennett et al., Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated, NEUROPHARM, 37(12), 1998, pp. 1603-1610